These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22542050)

  • 1. Spectacular evolution of reactive arthritis after early treatment with infliximab.
    Thomas-Pohl M; Tissot A; Banal F; Lechevalier D
    Joint Bone Spine; 2012 Oct; 79(5):524. PubMed ID: 22542050
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of reactive arthritis with infliximab.
    Oili KS; Niinisalo H; Korpilähde T; Virolainen J
    Scand J Rheumatol; 2003; 32(2):122-4. PubMed ID: 12737333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis.
    Meador R; Hsia E; Kitumnuaypong T; Schumacher HR
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S130-4. PubMed ID: 12463463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of adalimumab in poststreptococcal reactive arthritis.
    Sánchez-Cano D; Callejas-Rubio JL; Ortego-Centeno N
    J Clin Rheumatol; 2007 Jun; 13(3):176. PubMed ID: 17551391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current status of therapeutic approaches in spondyloarthropathies].
    Sieper J; Braun J
    Z Rheumatol; 2001 Dec; 60(6):458-63. PubMed ID: 11826741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of reactive arthritis with infliximab].
    Abdelmoula LC; Yahia CB; Testouri N; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
    Tunis Med; 2008 Dec; 86(12):1095-7. PubMed ID: 19213526
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful use of infliximab in the treatment of Reiter's syndrome: a case report and discussion.
    Gill H; Majithia V
    Clin Rheumatol; 2008 Jan; 27(1):121-3. PubMed ID: 17643185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of an HIV-infected patient with reactive arthritis treated with infliximab.
    Gaylis NB
    J Clin Rheumatol; 2012 Apr; 18(3):153-4. PubMed ID: 22426582
    [No Abstract]   [Full Text] [Related]  

  • 9. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab: a new treatment for rheumatoid arthritis.
    Emery P
    Hosp Med; 2001 Mar; 62(3):150-2. PubMed ID: 11291464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
    Moustou AE; Stratigos AJ; Vergou T; Gregoriou S; Georgala S; Danopoulou I
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):968-9. PubMed ID: 19207660
    [No Abstract]   [Full Text] [Related]  

  • 12. Infliximab in the treatment of an HIV positive patient with Reiter's syndrome.
    Gaylis N
    J Rheumatol; 2003 Feb; 30(2):407-11. PubMed ID: 12563704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease.
    Cepeda EJ; Williams FM; Ishimori ML; Weisman MH; Reveille JD
    Ann Rheum Dis; 2008 May; 67(5):710-2. PubMed ID: 18079191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon.
    Uthman I; Mroueh K; Arayssi T; Nasr F; Masri AF
    Semin Arthritis Rheum; 2004 Jun; 33(6):422-3. PubMed ID: 15260002
    [No Abstract]   [Full Text] [Related]  

  • 15. Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment.
    Harriman G; Harper LK; Schaible TF
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I61-4. PubMed ID: 10577975
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential use of TNF-α inhibitors in systemic sclerosis.
    Murdaca G; Spanò F; Contatore M; Guastalla A; Puppo F
    Immunotherapy; 2014; 6(3):283-9. PubMed ID: 24762073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and adverse reactions of the TNFalpha inhibitor infliximab in rheumatoid arthritis].
    Imagama T; Taguchi T
    Nihon Rinsho; 2013 Jul; 71(7):1209-13. PubMed ID: 23961668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tumor necrosis factor-alpha inhibitors on lung lesions with rheumatoid arthritis.
    Inoue K; Takano H; Yanagisawa R; Yoshikawa T
    Chest; 2003 Jul; 124(1):413-4; author reply 414. PubMed ID: 12853558
    [No Abstract]   [Full Text] [Related]  

  • 19. The application of infliximab (Remicade), a chimeric monoclonal antibody, in the treatment of rheumatic diseases.
    Kalden JR
    Isr Med Assoc J; 2000 Dec; 2 Suppl():11-2. PubMed ID: 11344856
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab as monotherapy in giant cell arteritis.
    Uthman I; Kanj N; Atweh S
    Clin Rheumatol; 2006 Feb; 25(1):109-10. PubMed ID: 15902519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.